General
Preferred name
PAPAVERINE
Synonyms
PAPAVERINE HYDROCHLORIDE ()
papaverine, S-P ()
Vasorin ()
Papaverini hydrochloridum ()
Papaver HCl ()
NSC-35443 ()
Artegodan ()
Papaverine hcl ()
Cardoverina ()
Papaverinum ()
NSC-136630 ()
Papaverine ()
Papaverine (hydrochloride) ()
P&D ID
PD009799
CAS
61-25-6
58-74-2
132-40-1
Tags
available
drug
natural product
drug candidate
Approved by
FDA
Drug indication
non-small cell lung carcinoma
Benign prostatic hyperplasia
Spasm
Drug Status
approved
investigational
Max Phase
3.0
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Papaverine is an alkaloid compound produced in plants. Although it is detected in opium poppy species, it is not structurally or pharmacologically similar to the opium alkaloids. (GtoPdb)
DESCRIPTION Papaverine is a nonxanthine phosphodiesterase inhibitor. It is used for the treatment of impotence and vasospasms. (Enamine Bioactive Compounds)
DESCRIPTION Phosphodiesterase inhibitor (LOPAC library)
Cell lines
2
Organisms
7
Compound Sets
22
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Ki Database
LOPAC library
Mcule NIBR MoA Box Subset
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
The Spectrum Collection
ZINC Tool Compounds
External IDs
137
Properties
(calculated by RDKit )
Molecular Weight
339.15
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
6
Ring Count
3
Aromatic Ring Count
3
cLogP
3.86
TPSA
49.81
Fraction CSP3
0.25
Chiral centers
0.0
Largest ring
6.0
QED
0.68
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
PDE
Member status
virtual
MOA
Phosphodiesterase PDE10A Inhibitors
phosphodiesterase inhibitor
Disease Area
cardiology, hematology, gastroenterology
Indication
myocardial infarction, angina pectoris, pulmonary embolism (PE), colitis, vascular spasm
Target
PDE10A, PDE4B, PDE5A
Therapeutic Class
Vasodilator Agents
Source data